naxagolide has been researched along with amphetamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, A; Rupniak, NM | 1 |
| Bloomfield, PM; Galineau, L; Ginovart, N; Houle, S; Kapur, S; Mizrahi, R; Seeman, P; Willeit, M; Wilson, AA | 1 |
| Galineau, L; Garcia, A; Ginovart, N; Houle, S; Kapur, S; Wilson, AA | 1 |
| Kapur, S; McCormick, PN; Seeman, P | 1 |
| Ginovart, N; McCormick, PN; Wilson, AA | 1 |
| Abanades, S; Beaver, JD; Colasanti, A; Gunn, RN; Huiban, M; Laruelle, M; Miller, SR; Plisson, C; Rabiner, EA; Searle, GE; Shotbolt, P; Tziortzi, AC; van der Aart, J | 1 |
| Carson, RE; Cosgrove, KP; Gallezot, JD; Huang, Y; Kloczynski, T; Labaree, D; Lim, K; Morris, ED; Pittman, B; Rabiner, EA; Ridler, K; Weinzimmer, D; Zheng, MQ | 1 |
| Boileau, I; Chugani, B; Houle, S; Kish, SJ; Lobo, DS; Payer, D; Warsh, J; Wilson, AA; Zack, M | 1 |
| Anderson, GM; Baldan, LC; Billingslea, E; Bloch, MH; Crowley, M; de Araujo, I; Ding, YS; Ercan-Sencicek, AG; Gallezot, JD; Gorczyca, R; Hughes, ZA; Krusong, K; Krystal, JH; Leventhal, BL; Loring, E; Mayes, L; Ohtsu, H; Panza, KE; Pittenger, C; Pogorelov, V; Rapanelli, M; State, MW; Wasylink, S; Williams, KA | 1 |
9 other study(ies) available for naxagolide and amphetamine
| Article | Year |
|---|---|
Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Dopamine Agonists; Grooming; Guinea Pigs; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Neurokinin A; Neurokinin-1 Receptor Antagonists; Oxazines; Piperidines; Receptors, Neurokinin-1; Stereoisomerism; Substance P | 1994 |
Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Topics: Amphetamine; Animals; Binding Sites; Binding, Competitive; Brain; Brain Chemistry; Carbon Radioisotopes; Cats; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Oxazines; Positron-Emission Tomography; Presynaptic Terminals; Raclopride; Receptors, Dopamine D2; Synaptic Transmission | 2006 |
In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Topics: Amphetamine; Animals; Binding, Competitive; Brain; Brain Chemistry; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Male; Molecular Structure; Oxazines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2006 |
Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.
Topics: Adrenergic Agents; Amphetamine; Animals; Binding, Competitive; Corpus Striatum; Dopamine; Dopamine Agonists; Male; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2007 |
Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.
Topics: Amphetamine; Anesthesia; Animals; Cats; Cerebellum; Dopamine; Dopamine D2 Receptor Antagonists; Isoflurane; Male; Neostriatum; Oxazines; Positron-Emission Tomography; Raclopride; Radioisotopes; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Time Factors | 2011 |
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.
Topics: Adult; Amphetamine; Binding, Competitive; Brain; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Ligands; Male; Middle Aged; Oxazines; Positron-Emission Tomography; Protein Binding; Raclopride; Radioligand Assay; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Sensitivity and Specificity | 2012 |
Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Macaca mulatta; Magnetic Resonance Imaging; Nicotine; Nicotinic Agonists; Oxazines; Positron-Emission Tomography; Protein Binding; Raclopride | 2014 |
In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO.
Topics: Adult; Amphetamine; Brain; Dopamine; Dopamine Agents; Dopamine Agonists; Gambling; Humans; Male; Models, Neurological; Oxazines; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Dopamine D3; Severity of Illness Index | 2014 |
Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.
Topics: Adolescent; Adult; Amphetamine; Animals; Brain; Child; Dopamine Agonists; Dopamine Antagonists; Exploratory Behavior; Female; Histidine Decarboxylase; Humans; Male; Maze Learning; Mice; Mice, Knockout; Middle Aged; Mutation; Oxazines; Raclopride; Radionuclide Imaging; Stereotyped Behavior; Time Factors; Tourette Syndrome; Tryptophan; Young Adult | 2014 |